MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Harmony Biosciences Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

31.89 0.63

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

31.8

Max

32.22

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-3.9M

46M

Pardavimai

-17M

185M

P/E

Sektoriaus vid.

12.061

40.527

Pelnas, tenkantis vienai akcijai

0.779

Pelno marža

24.663

Darbuotojai

268

EBITDA

-10M

56M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+59.76% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

75M

1.8B

Ankstesnė atidarymo kaina

31.26

Ankstesnė uždarymo kaina

31.89

Naujienos nuotaikos

By Acuity

50%

50%

157 / 375 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-03 23:45; UTC

Įsigijimai, susijungimai, perėmimai

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

2025-07-03 23:42; UTC

Rinkos pokalbiai

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

2025-07-03 23:41; UTC

Rinkos pokalbiai

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

2025-07-03 23:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-03 23:15; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

2025-07-03 22:59; UTC

Rinkos pokalbiai

Uranium Market About to Enter Lull -- Market Talk

2025-07-03 22:58; UTC

Rinkos pokalbiai

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

2025-07-03 22:47; UTC

Rinkos pokalbiai

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

2025-07-03 22:21; UTC

Uždarbis

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

2025-07-03 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-07-03 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-03 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-03 20:41; UTC

Rinkos pokalbiai

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

2025-07-03 20:41; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-03 19:28; UTC

Rinkos pokalbiai

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

2025-07-03 19:03; UTC

Rinkos pokalbiai

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

2025-07-03 18:34; UTC

Rinkos pokalbiai

Gold Has Winning Week, But Down Day -- Market Talk

2025-07-03 18:18; UTC

Rinkos pokalbiai

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

2025-07-03 18:06; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-03 18:06; UTC

Rinkos pokalbiai

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

2025-07-03 17:27; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Continues to Slide -- Market Talk

2025-07-03 16:55; UTC

Uždarbis

Travel Stocks Could Offer Investors a Glorious -2-

2025-07-03 16:55; UTC

Uždarbis

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

2025-07-03 16:20; UTC

Rinkos pokalbiai

Correction to Health Care Roundup: Market Talk

2025-07-03 16:15; UTC

Rinkos pokalbiai

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

2025-07-03 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-07-03 16:05; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-03 16:05; UTC

Rinkos pokalbiai

Gold Futures Fall Following Jobs Report -- Market Talk

2025-07-03 15:47; UTC

Uždarbis

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

2025-07-03 15:36; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

59.76% į viršų

12 mėnesių prognozė

Vidutinis 51.17 USD  59.76%

Aukščiausias 70 USD

Žemiausias 31 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

6 ratings

5

Pirkti

0

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Very Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

157 / 375 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.